Wbh Advisory Inc Amgen Inc Transaction History

Wbh Advisory Inc

$1.05 Billion
Q3 2024

A detailed history of Wbh Advisory Inc transactions in Amgen Inc stock. As of the latest transaction made, Wbh Advisory Inc holds 1,843 shares of AMGN stock, worth $486,552. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,843

Previous 1,644 12.1%

Holding current value

$486,552

Previous $513,000 15.59%

% of portfolio

0.06%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$309.38 - $337.38 $61,566 - $67,138	199 Added 12.1%	1,843 $593,000
Q2 2024 Jul 11, 2024	BUY	$262.75 - $319.31 $262 - $319	1 Added 0.06%	1,644 $513,000
Q1 2024 Apr 16, 2024	SELL	$268.87 - $324.56 $8,872 - $10,710	-33 Reduced 1.97%	1,643 $467,000
Q4 2023 Jan 09, 2024	SELL	$255.7 - $288.46 $3,835 - $4,326	-15 Reduced 0.89%	1,676 $482,000
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $3,061 - $3,800	14 Added 0.83%	1,691 $454,000
Q2 2023 Jul 12, 2023	BUY	$214.27 - $253.37 $214 - $253	1 Added 0.06%	1,677 $372,000
Q1 2023 Apr 20, 2023	BUY	$225.79 - $275.2 $4,967 - $6,054	22 Added 1.33%	1,676 $405,000
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $224 - $253	1 Added 0.06%	1,654 $373,000
Q1 2022 Apr 29, 2022	SELL	$219.27 - $242.57 $24,996 - $27,652	-114 Reduced 6.45%	1,653 $399,000
Q4 2021 Jan 28, 2022	BUY	$198.88 - $227.6 $198 - $227	1 Added 0.06%	1,767 $397,000
Q3 2021 Oct 25, 2021	BUY	$212.27 - $248.7 $849 - $994	4 Added 0.23%	1,766 $375,000
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $467 - $518	2 Added 0.11%	1,762 $432,000
Q1 2021 Apr 19, 2021	SELL	$221.91 - $258.6 $3,106 - $3,620	-14 Reduced 0.79%	1,760 $438,000
Q4 2020 Jan 21, 2021	BUY	$216.38 - $257.67 $4,760 - $5,668	22 Added 1.26%	1,774 $448,000
Q3 2020 Oct 27, 2020	BUY	$234.65 - $260.95 $7,743 - $8,611	33 Added 1.92%	1,752 $445,000
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $395 - $485	2 Added 0.12%	1,719 $405,000
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $364 - $483	2 Added 0.12%	1,717 $348,000
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $4,541 - $5,836	-24 Reduced 1.38%	1,715 $413,000
Q3 2019 Oct 25, 2019	BUY	$174.11 - $208.62 $348 - $417	2 Added 0.12%	1,739 $336,000
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $166 - $195	1 Added 0.06%	1,737 $320,000
Q1 2019 Apr 22, 2019	BUY	$180.87 - $203.88 $361 - $407	2 Added 0.12%	1,736 $329,000
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $178 - $208	1 Added 0.06%	1,734 $337,000
Q3 2018 Oct 29, 2018	BUY	$185.29 - $208.89 $370 - $417	2 Added 0.12%	1,733 $359,000
Q2 2018 Jul 31, 2018	BUY	$166.05 - $186.51 $166 - $186	1 Added 0.06%	1,731 $319,000
Q1 2018 Apr 30, 2018	BUY	$169.43 - $198.0 $169 - $198	1 Added 0.06%	1,730 $294,000
Q4 2017 Jan 31, 2018	BUY	$168.79 - $188.59 $337 - $377	2 Added 0.12%	1,729 $300,000
Q3 2017 Nov 29, 2017	BUY	$167.29 - $191.0 $288,909 - $329,857	1,727	1,727 $322,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wbh Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wbh Advisory Inc with notifications on news.

Account